Assembly Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $13,374 | $8,212 | $42,469 | $10,789 |
Gross Profit | 13,354 | 8,186 | 42,437 | -5,798 |
EBITDA | -3,837 | -9,053 | 22,122 | -9,164 |
EBIT | -3,857 | -9,079 | 22,090 | -9,196 |
Net Income | -3,857 | -9,079 | 22,090 | -9,196 |
Net Change In Cash | 13,374 | 8,212 | 42,469 | 10,789 |
Free Cash Flow | -15,488 | -22,116 | 14,213 | -15,175 |
Cash | 32,286 | 31,120 | 58,450 | 22,534 |
Basic Shares | 18,853 | 16,900 | 11,210 | 7,655 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $72,303 | $28,520 | $7,163 | $0 |
Gross Profit | 72,174 | -27,413 | -41,737 | -498 |
EBITDA | -5,993 | -39,718 | -60,745 | -93,616 |
EBIT | -6,122 | -39,847 | -61,195 | -94,114 |
Net Income | -6,122 | -40,177 | -61,228 | -92,070 |
Net Change In Cash | 72,303 | 28,520 | 7,163 | 0 |
Cost of Revenue | 6,791 | |||
Free Cash Flow | -41,159 | -51,145 | 22,488 | -84,565 |
Cash | 58,450 | 38,344 | 19,841 | 52,418 |
Basic Shares | 11,210 | 6,004 | 4,577 | 4,034 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.20 |
2026-03-31 | -$0.54 |
2025-12-31 | $2.48 |
2025-09-30 | -$0.72 |